Comparison of granulocyte colony-stimulating factor (G-CSF)--mobilized peripheral blood progenitor cells and G-CSF--stimulated bone marrow as a source of stem cells in HLA-matched sibling transplantation.

[1]  N. Ueno,et al.  Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation. , 1999, Blood.

[2]  M. Kamel,et al.  Peripheral blood vs bone marrow as a source for allogeneic hematopoietic stem cell transplantation , 1999, Bone Marrow Transplantation.

[3]  G. Hill,et al.  Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease. , 1999, Blood.

[4]  R. Vij,et al.  Long-term follow-up of high-risk allogeneic peripheral-blood stem-cell transplant recipients: graft-versus-host disease and transplant-related mortality. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  M. Beksac,et al.  A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: a focus on the incidence of graft-vs.-host disease and relapse. , 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[6]  J. Crawford,et al.  Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease. , 1998, The Journal of clinical investigation.

[7]  M. Mielcarek,et al.  Production of interleukin-10 by granulocyte colony-stimulating factor-mobilized blood products: a mechanism for monocyte-mediated suppression of T-cell proliferation. , 1998, Blood.

[8]  J. Crawford,et al.  Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation. , 1998, The Journal of clinical investigation.

[9]  A. Raptis,et al.  T cell-depleted granulocyte colony-stimulating factor (G-CSF) modified allogeneic bone marrow transplantation for hematological malignancy improves graft CD34+ cell content but is associated with delayed pancytopenia , 1998, Bone Marrow Transplantation.

[10]  M. Mielcarek,et al.  Impaired induction of the CD28-responsive complex in granulocyte colony-stimulating factor mobilized CD4 T cells. , 1998, Blood.

[11]  K. Sullivan,et al.  Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. , 1997, Blood.

[12]  V. Najfeld,et al.  A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G-CSF , 1997, Bone Marrow Transplantation.

[13]  J. Crawford,et al.  Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. , 1997, Blood.

[14]  J. Serody,et al.  Prevention of infections in bone marrow transplant recipients. , 1997, Infectious disease clinics of North America.

[15]  J. Armitage,et al.  Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  R. Storb,et al.  Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. , 1996, Blood.

[17]  J. Serody,et al.  Thrombocytopenia in allogeneic peripheral blood stem cell collections , 1996, Transfusion.

[18]  J. Ferrara,et al.  Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. , 1995, Blood.

[19]  G. Elfenbein,et al.  A prospective randomized trial comparing blood- and marrow-derived stem cells for hematopoietic replacement following high-dose chemotherapy. , 1995, Journal of hematotherapy.

[20]  N. Schmitz,et al.  Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor) , 1995, Blood.

[21]  Giralt,et al.  Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. , 1995, Blood.

[22]  H. Deeg,et al.  Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia? , 1993, Blood.

[23]  C. Perreault,et al.  Acute graft-versus-host disease prophylaxis with methotrexate and cyclosporine after busulfan and cyclophosphamide in patients with hematologic malignancies. , 1993, Blood.

[24]  K. Akashi,et al.  Cyclosporine combined with methylprednisolone or methotrexate in prophylaxis of moderate to severe acute graft-versus-host disease. , 1993, Bone marrow transplantation.

[25]  F. Appelbaum,et al.  Phase I study of busulfan and cyclophosphamide in preparation for allogeneic marrow transplant for patients with multiple myeloma. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  H. Deeg,et al.  Graft‐versus‐host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long‐term follow‐up of a controlled trial , 1989, British journal of haematology.

[27]  H. Deeg,et al.  Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial. , 1989, Blood.

[28]  G. Santos.  Busulfan (Bu) and cyclophosphamide (Cy) for marrow transplantation. , 1989, Bone marrow transplantation.

[29]  P. Neiman,et al.  CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.

[30]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .